Ortin Global

10.54
-0.19
(-1.77%)
Market Cap
8.57 Cr
EPS
-9.89
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
23.90
52 Week Low
9.64
PB Ratio
4.14
Debt to Equity
0.60
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,766.50
#1 4,23,842.52
36.24
#1 49,887.20
12.06
#1 9,648
13.77
52.54
5,977.00
1,58,670.57
78.92
8,184.00
0.89
1,600
#1 64.53
61.32
1,487.00
1,20,092.34
24.42
26,520.70
14.17
4,155
47.38
50.90
3,191.50
1,08,014.86
59.79
10,785.70
11.59
1,656
13.54
54.71
2,442.90
1,00,788.81
49.11
10,615.60
19.57
1,942
-16.38
48.65
1,150.50
96,004.09
#1 18.02
28,905.40
12.36
5,578
1.69
48.72
2,018.50
92,152.79
32.97
20,141.50
#1 19.94
1,936
38.82
52.90
874.45
87,990.13
19.68
19,831.50
13.82
3,831
29.92
52.04
1,158.40
67,280.06
19.72
29,559.20
17.55
3,169
-10.04
51.90
30,040.00
63,832.90
48.19
6,097.20
10.80
1,201
16.01
51.66

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
-62.30 %
Net Income Growth
7,900.00 %
Cash Flow Change
-1,816.00 %
ROE
33,010.47 %
ROCE
-7,190.55 %
EBITDA Margin (Avg.)
-3,101.19 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
61
64
62
80
168
198
8
8
6
2
1
Expenses
54
57
56
74
161
192
7
8
6
9
4
EBITDA
7
7
6
6
7
6
1
1
1
-6
-4
Operating Profit %
11 %
9 %
9 %
7 %
4 %
3 %
15 %
5 %
9 %
-310 %
-929 %
Depreciation
2
2
2
2
2
2
0
0
0
0
0
Interest
4
3
3
4
3
3
1
1
0
1
0
Profit Before Tax
1
1
1
1
2
1
0
-1
-0
-7
-4
Tax
0
1
1
0
1
1
-1
-0
0
1
1
Net Profit
1
1
1
1
1
-1
1
-0
-0
-8
-5
EPS in ₹
0.53
0.49
0.30
0.40
0.76
-0.33
1.16
-0.49
-0.12
-9.89
-5.90

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
67
65
62
74
105
117
21
21
21
7
Fixed Assets
22
22
21
20
21
23
14
14
14
0
Current Assets
43
31
38
52
82
92
6
6
7
6
Capital Work in Progress
0
0
0
0
1
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
45
44
40
53
83
94
7
6
7
7
Total Liabilities
67
65
62
74
105
117
21
21
21
7
Current Liabilities
37
26
31
42
72
84
8
8
7
2
Non Current Liabilities
8
16
8
8
8
9
2
2
3
2
Total Equity
22
23
23
24
25
24
11
11
11
3
Reserve & Surplus
6
6
7
7
8
7
3
3
3
-5
Share Capital
17
17
17
17
17
17
8
8
8
8

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
1
-0
-0
1
0
-1
8
2
1
4
Investing Activities
0
-1
-1
-1
-3
-3
0
-0
0
12
Operating Activities
-1
1
2
2
7
3
18
2
-0
-5
Financing Activities
2
0
-1
0
-3
-1
-10
-1
1
-4

Share Holding

% Holding
Jan 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
10.40 %
10.40 %
15.68 %
15.68 %
15.68 %
15.68 %
15.68 %
15.68 %
15.68 %
21.51 %
7.36 %
7.37 %
7.36 %
1.23 %
1.23 %
1.23 %
1.23 %
1.23 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
6.25 %
6.25 %
6.25 %
6.53 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
87.23 %
85.95 %
74.20 %
79.86 %
79.33 %
79.26 %
80.15 %
77.72 %
79.59 %
73.83 %
86.93 %
86.94 %
86.06 %
92.04 %
85.84 %
83.55 %
84.26 %
85.32 %
Others
2.37 %
3.64 %
10.12 %
4.46 %
4.99 %
5.06 %
4.17 %
6.60 %
4.73 %
4.66 %
5.71 %
5.69 %
6.58 %
6.73 %
6.68 %
8.97 %
8.26 %
6.92 %
No of Share Holders
0
7,325
7,860
12,302
11,947
12,819
12,662
12,571
12,449
12,585
12,181
11,836
12,314
12,192
11,952
12,165
12,094
12,144

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
12 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Feb 2025 16.81 16.22
13 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2024 20.00 19.32
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 22.56 20.81
11 Apr 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
11 Apr 2024 21.30 21.85
05 Apr 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
05 Apr 2024 21.76 21.03
13 Feb 2024 CHANGE OF NAME Change Of Name
NA
13 Feb 2024 21.30 21.30
14 Dec 2023 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
14 Dec 2023 19.03 19.79

Announcements

Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A8 days ago
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2Apr 10, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Board Meeting Outcome for Outcome Of Board MeetingApr 01, 2025
Closure of Trading WindowMar 24, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 14, 2025
Integrated Filing (Financial)Feb 12, 2025
UN-AUDITED FINANCIAL RESULTS FOR QUARTER ENDED 31-12-2024Feb 12, 2025
Board Meeting Outcome for OUTCOME OF BOARD MEETING FOR APPROVAL OF UN-AUDITED FINANCIALS OF THE COMPANY FOR THE QUARTER NEDED 31-12-2024Feb 12, 2025
Board Meeting Intimation for Approval Of Un-Audited Financials Of The Company For The Quarter Ended 31-12-2024Feb 07, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 11, 2025
Closure of Trading WindowDec 27, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 19, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 15, 2024
Un-Audited Results For The Quarter Ended On 30-09-2024Nov 13, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On 13-11-2024Nov 13, 2024
Board Meeting Intimation for Un-Audited Financial Results For The Quarter And Half Year Ended 30.09.2024Nov 04, 2024
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerNov 04, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 24, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 24, 2024
Scrutinizer''s ReportSep 30, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 30, 2024
Closure of Trading WindowSep 28, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held As On 25.09.2024Sep 25, 2024
Notice For The Annual General Meeting Of The CompanySep 07, 2024
Reg. 34 (1) Annual Report.Sep 07, 2024
Board Meeting Outcome for Out Come Of BMAug 13, 2024
Un-Audited Financial Results For The Quarter Ended 30-06-2024Aug 13, 2024
Board Meeting Intimation for 1. Un-Audited Financial Results For The Quarter Ended 30.06.2024Aug 06, 2024
Postponement Of Board Meeting Scheduled To Be Held On 31.07.2024Jul 31, 2024
Board Meeting Intimation for Board Meeting To Be Held On 31.07.2024Jul 24, 2024
Announcement under Regulation 30 (LODR)-Change of Company NameJul 24, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 20, 2024
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerJul 18, 2024
Closure of Trading WindowJun 29, 2024
Announcement under Regulation 30 (LODR)-Change in Registered Office AddressMay 30, 2024
Audited Financial Results For The Quarter And Financial Year Ended 31.03.2024May 30, 2024
Board Meeting Outcome for Outcome Of Board Meeting For The Quarter And Year Ended 31.03.2024 Under Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.May 30, 2024
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2024
Board Meeting Intimation for Audited Results For The Quarter And Year Ended 31.03.2024May 22, 2024
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2Apr 20, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Apr 17, 2024
Disclosure Under Regulation 40(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 For The FY Ending 31.03.2024Apr 17, 2024
Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31.03.2024.Apr 17, 2024
Shareholder Meeting / Postal Ballot-Scrutinizers ReportApr 11, 2024
Shareholder Meeting / Postal Ballot-Outcome of EGMApr 11, 2024
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerApr 06, 2024
Clarification On Price MovementApr 06, 2024
Clarification sought from Ortin Laboratories LtdApr 06, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Apr 04, 2024

Technical Indicators

RSI(14)
Neutral
44.23
ATR(14)
Less Volatile
0.77
STOCH(9,6)
Neutral
34.26
STOCH RSI(14)
Neutral
34.74
MACD(12,26)
Bullish
0.02
ADX(14)
Weak Trend
20.46
UO(9)
Bearish
49.15
ROC(12)
Downtrend And Accelerating
-4.45
WillR(14)
Neutral
-61.73